BECTON DICKINSON ORGANIZATIONAL BACKGROUND

Group Members
Hardik Gandhi Roll No. 8
Sneha Mhatre Roll No. 19
Kingslin Nadar Roll No. 21
Sandeep Nair Roll No. 23
Sumit Panjwani Roll No. 26

KINGSLIN NADAR ROLL NO. 21

AGENDA
About the Company
Mr. Clateo Castellini and his
concerns
SWOT Analysis

Issues

DRBC Model

Key Takeaways

ABOUT THE COMPANY

Founded in 1897 by Maxwell W. Becton & Fairleigh S. Dickinson

Initially as an importer of Medical devices

Later emerged as a major manufacturer of medical supplies & diagnostic

equipment.

First manufacturer of modern stethoscope, insulin syringe and vacuum tubes

Headquartered in Franklin Lakes, New Jersey, U.S.

BD employs nearly 30,000 associates in more than 50 countries throughout the

world

Manufacturing facilities in 12 countries

ABOUT THE COMPANY

Went public in 1962

By 1996 became the largest producer of medical syringes, needles & tissue collection devices.

Larger supplier of hospital laboratory instrumentation

Products sold in 70 countries

International sales accounts for almost half of revenue.

- In United States : 5 - 15% of BDs sales to public entities

- Other than US : 50 - 90% of BDs sales to public entities

Market Leader

Diabetes-care
devices - 80%

Pharmaceutical
systems 70%

Hypodermic
syringes 50%

ABOUT THE COMPANY

BD focuses 3 worldwide business segments:

BD Medical

Worlds leading suppliers of medical devices and a

leading innovator in injection and infusion-based
drug

BD Diagnostics

Leading provider of products for the safe collection

and transport of diagnostics specimens, as well as
instruments

BD Biosciences

World leader in bringing innovative diagnostic and

research tools to life scientists, clinical researchers,
laboratory professionals and clinicians

SANDEEP NAIR ROLL NO. 23

ABOUT CLATEO CASTELLINI

Chairman and CEO in 1994

Personality traits : Responsible and process oriented

Make things easier at workplace

Carries great amount of experience

Well aware of the company whereabouts

Accepts challenges, result-oriented

HIS CONCERNS

Improvement in BDs financial performance

Foresee long term goals

Achieve strong performance after crossing 100th year at BD

His main objectives

- Global perspective

Becton Dickinson as best managed & admired company

Becton Dickinson a company known for eliminating suffering & death from disease in the world

- Within the company

To reshape the companies culture

To bring ethical practices in effect.

HARDIK GANDHI ROLL NO. 8

SWOT ANALYSIS

Strength
Solid, Long standing reputation within
industry
Largest producer of medical syringes,
needles & tissue collection devices.
Largest supplier of hospital laboratory
instrumentation

Weakness
Lack of standardized ethical procedures
Employees looking for greater guidance
from top management regarding ethical
practice to follow
Going through a stressful time of
ambitious growth that presents
challenges

Products sold in 70 countries

Internal focus on mission and values

Moving into new markets and shifting

away from distributor-based sales

SWOT ANALYSIS

Opportunities
Build on existing relationships with
customers and vendors worldwide
Aging populations throughout the
industrial world
New Emerging markets in China &
India

Threats
Increased competition within industry
Cultural differences and challenges
worldwide
Cope with complex legal & regulatory
environment
Dynamic & fast changing market

Become a world leader in ethical and

lawful behavioral studies and education

SUMIT PANJWANI ROLL NO. 26

ISSUES

BD being an ambitious company needed new customers

Dennis Santucci was a controller of payments

Difficulty distinguishing between normal and acceptable or improper and unlawful payments

Governed under the US Foreign Corruption Practices Act

Ethical Challenges -

- A prospective customer wanted to go to training in California and visit Disneyland later with his family
- A purchasing official wanted a 2% processing fees in cash before placing the order
- A purchasing official of a new company wanted computer equipment's and refrigerator as donations

ISSUES

Paul McAuliffe, Director of Ethics and Business Practices knew employees needed guidance on such

issues.

Employees had questions about

- Acceptability of certain issues

- Gratuities
- Entertainment Costs

Solution

- Started a policy making group - Global One Company Operations

- Business heads and regional manager undertook to review the situation
- Approval on such issues by top executives

SNEHA MHATRE ROLL NO. 19

DRBC MODEL

Duties

Rights

Best
Practices

Commitment

DRBC MODEL
Duties

Ensure best quality of medical products & equipments

Involved in advanced research, discovery of new drugs & vaccines

Legally obligated to act in a socially responsible manner

Refrain from frauds

Protect human health & safety

Business should respect, protect, and make efforts to restore the environment

Increase its shareholder wealth

DRBC MODEL
Rights

Consumers :- to get best quality medical products

Government :- to anticipate that the company abides by the law.

Society :- to expect the company to behave in socially responsible manner

Shareholder:-

- To receive notice of a shareholders' meeting

- To raise an issue related to the businesses conducted
- To expect increase in shareholder wealth

DRBC MODEL
Best Practices

BD follows

- WHO's Best Practices for Injections and Related Procedures Toolkit

- CDC's Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings
2007

Active Participants in

- Safe Injection Practices Coalition,

- United for Medical Research (UMR)

DRBC MODEL
Best Practices

Meeting Unmet Health Needs

Ensuring Good Governance and Ethics

Product Safety and Performance

Protecting the Environment

Making BD an Even Better Place to Work

DRBC MODEL
Commitments

Purpose

- Helping all people live healthy lives

BD committed to most ethical business practices

Reduce global environmental impact

Ensure that their customers n suppliers operate in ways environmentally responsible

Committed to Pink Ribbon Red Ribbon, National Cancer Coalition

SUMIT PANJWANI ROLL NO. 26

KEY TAKEAWAYS

A lot of Utilitarianism exists where results are important

A lack of Universalism exists wherein the means dont justify the ends

Thought Guidelines like Good Clinical Practises exists, various unethical practices are followed by

companies

A Stronger Government role should exist to control unethical practises

Ethics and morality to be a part of the companies value system

Companies should follow the policies and not keep it just on paper.

THANK YOU

General Ethical issues across the Industry

Medical practitioners and the healthcare industry serve interests that sometimes overlap and sometimes
conflict.

There is strong evidence that associations between industry and doctors influence the behavior of the
latter in relation to both clinical decision making and the conduct of research.

In view of the risk of compromising relationships with patients and the integrity of the research process,
doctors tend to be biased.

Clearly articulated procedures are sometimes not well developed to deal with specific issues such as travel
subsidies, receipt of gifts, sponsorship of conferences and continuing education activities, and dualities of
interest arising in clinical and research settings

Once technologies are directed towards making humans 'better than well', assuming the body is
manipulative in nature according to individual preferences, then real ethical and theological concerns arise.
The abuse of technology threatens inherent human dignity and challenges the equal moral status of all
human persons

Other ethical issues are that are common in the industry : -

When should life-sustaining treatments like breathing machines or feeding tubes be started, continued,
or stopped?

What should family members and health care professionals do if a patient refuses treatment that
promises to be medically helpful?

Who should make health care decisions for patients when they are unable to communicate or decide
for themselves?

What should patients do when they do not understand what professionals are saying and feel they are
not offered the opportunity to participate in their own health care decisions?

COMPANY : HOSPITAL CORPORATION OF AMERICA (HCA)

HCA is based out of Nashville,USA and its one of the competitors of BD.

The corporation initially had federal lobbyist and had registered lobbying presence across 12 states.

In 2000,The company had paid out a total of $1.7billion in fines, refunds and lawsuit settlements admitting that through its subsidiaries it
had -

Offered financial incentives to doctors in violation of antikickback laws,

falsified records to generate high payments for minor treatments or treatments that never occurred

Charged laboratory tests that never occurred

Charged for home-health care for patients who did not qualify for it

Falsely labeled ads as community education

Ever since these issues occurred, company has designed a code of conduct and enforced ethical practices in the long run ( It has
been rated as one of the best ethical company couple of years ago)